NexMed Inc. (NEXM) Stock Quote

Stock Web

Detailed Quote for NexMed Inc. (NEXM)

close 52 Week Information

52 Week High

January 13,2010

Close: 12.5835

52 Week Low

October 28,2009

Close: 1.80

Today

5d

1m

3m

1y

more

Last Price
1.99

Change $
0.03

Change %
1.53%

Tick

Bid
1.98

Bid Size
100

Ask
1.99

Ask Size
200

Open
2.00

High
2.07

Low
1.95

Prev Close
1.96

Last Trade
10:33

Volume
16.99 k

52 Wk Hi
12.5835

52 Wk Low
1.80

Market Cap
25.52 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
12,824,692

EPS (TTM)
-6.92

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Small Caps (NSC) Exchange
NSC

News and Media for NexMed Inc. (NEXM)

Sector News | Topic News

News for NEXM

Wed, Aug 25, 2010

11:00 AM

NexMed To Present at the Rodman & Renshaw 12th Annual Healthcare Conference - Business Wire

Mon, Aug 23, 2010

9:00 AM

NexMed Receives Additional Patent Coverage for Israel - Business Wire

Wed, Aug 11, 2010

9:15 AM

NexMed Announces 2010 Second Quarter Financial Results Conference Call - Business Wire

Mon, Jul 26, 2010

12:36 PM

Mohamed Hachicha, Ph.D. Joins NexMed, Inc. as Vice President-Research and Development for NexMed, USA - Business Wire

Wed, Jul 07, 2010

8:30 AM

NexMed Regains Compliance with NASDAQ Listing Requirements - Business Wire

Mon, Jun 28, 2010

12:09 PM

NexMed to Present PrevOnco(R) Data at ILCA Annual Conference - Business Wire

Thu, Jun 24, 2010

1:20 PM

NexMed Announces First Patent Allowance for Vitaros(R) in Japan - Business Wire

Wed, Jun 23, 2010

1:54 PM

NexMed Receives Screening Acceptance Letter from Health Canada for Vitaros(R) - Business Wire

Tue, Jun 22, 2010

9:15 AM

NexMed Announces Appointment of Deirdre Y. Gillespie, M.D. to the Board of Directors - Business Wire

Mon, Jun 21, 2010

9:50 AM

Emerging Stock Report Initiates Independent Research Coverage on NexMed, Inc. - Globe Newswire

Tue, Jun 15, 2010

2:48 PM

NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioequivalent to Talconex(R) - Business Wire

9:33 AM

NexMed Announces Pre-Clinical Results Showing That Its Proprietary Calcipotriene Betamethasone Psoriasis Formulation is Bioequvalent to Talconex(R) - Business Wire

Thu, Jun 10, 2010

1:30 PM

NexMed Provides Update on Canadian Filing for Vitaros(R) - Business Wire

Fri, May 07, 2010

6:52 AM

BioTech Stock Alert for NexMed Inc. Issued by MicroStockProfit - Globe Newswire

Fri, Mar 12, 2010

6:51 AM

Biotech Market Watch for NexMed Inc. Issued by Beacon Equity - Globe Newswire

Tue, Feb 16, 2010

6:51 AM

Biopharma Stock Alert for NexMed Inc. Issued by Beacon Equity - Globe Newswire

Tue, Feb 09, 2010

9:05 AM

Liberty Analytics Co. Initiates Independent Research Coverage on NexMed, Inc. - Globe Newswire

Thu, Jan 14, 2010

6:51 AM

Pharmaceutical Stock Alert for NexMed Inc. Issued by BeaconEquity - Globe Newswire

Wed, Jan 13, 2010

10:14 AM

Skymark Research Initiates Independent Research Coverage on NexMed, Inc. - Globe Newswire

Wed, Nov 25, 2009

6:50 AM

Beacon Equity Issues Technical Trading Overview for NexMed Inc. - Globe Newswire

More News for NEXM >>

Tags for NexMed Inc.

Research stocks or mutual funds related to NexMed Inc. by keywords or tags. Find companies that have a similar focus to NEXM. The keywords below have been associated to NEXM by either user submission or electronic means.

pharmaceutical intermediate pharmaceutical courses biotech research pharmaceutical branding biotech news pharmaceutical market pharmaceuticals companies generic pharmaceutical jobs in pharmaceutical mgi pharma pharmaceutical research and development pharmaceutical supplies pharmaceutical manufacturing company dupont pharmaceuticals pharma marketing pharmaceutical industry marketing pharma manufacturing pharmaceuticals jobs pharma license novartis pharmaceuticals gmp pharmaceutical biotechnology jobs clinical research pharmaceutical class pharmaceutical ingredients pharmaceutical cro pharmaceutical sales pharma pharmaceutical distributors pharmaceutical solution medical research pharmaceutical sales rep biotech biotechnology research Drugs pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation jobs biotech pharmaceutical article pfizer pharmaceuticals contract pharmaceutical pharmaceutical consulting a career in pharmaceutical sales pharmaceutical industry pharmaceutical market analysis pharmaceutical studies pharmaceutical advances pharmaceutical distributor pharmaceutical jobs

Bookmark With:

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.